Archive: 02/10/2013

New class of drugs lowers cholesterol in first human trial

A single dose of the small interfering ribonucleic acid (siRNA) drug candidate ALN-PCS cut levels of LDL cholesterol (bad cholesterol) in healthy volunteers by up to 57%, and 40% on average more than those given a placebo, ...

page 1 from 7